 
                 
                Inhouse product
Indications
Ticstop is indicated
for the treatment of chorea associated with Huntington's disease,
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
 
Pharmacology
Tetrabenazine is a
drug formerly used as an antipsychotic but now used primarily in the
symptomatic treatment of various hyperkinetic disorders, It is a vesicular
monoamine transporter-2 (VMAT-2) inhibitor that used as symptomatic treatment
of chorea associated with Huntington's disease.
Dosage & Administration
Recommended dosing for
Tetrabenazine: Tetrabenazine can be
taken with or without food. Individualization of dose with careful weekly
titration is required.
Pediatric
& geriatric use: Safety and
effectiveness in pediatric patients have not been established. The
pharmacokinetics of Tetrabenazine and its primary metabolites have not been
formally studied in geriatric subjects.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
 
Interaction
With medicine: Strong
CYP2D6 Inhibitors: A reduction in Ticstop dose may be necessary when adding a
strong CYP2D6 inhibitor (e.g., fluoxetine, paroxetine, quinidine) in patients
maintained on a stable dose of Ticstop.
Reserpine: Reserpine binds irreversibly to VMAT2, and the duration of its
effect is several days. At least 20 days should elapse after stopping reserpine
before starting Ticstop, Ticstop and Reserpine should not be used concomitantly.
With food & others: No interaction with food, can be taken with or without
food.
Contraindications
Tetrabenazine is
contraindicated in:
Side Effects
Common: Most common adverse reactions (>10% and
at least 5% greater than placebo) were-Sedation/somnolence, fatigue, insomnia,
depression, akathisia, anxiety/anxiety aggravated & nausea.
Rare: Suicidal thoughts, neuroleptic malignant
syndrome, a reaction characterized by fever, muscle rigidity and confusion
& pneumonia.
Pregnancy & Lactation
There are no adequate
data on the developmental risk associated with the use of Tetrabenazine in
pregnant women. There are no data on the presence of tetrabenazine or its
metabolites in human milk.
Precautions & Warnings
The benefit and
potential for adverse effects such as worsening mood, cognition, rigidity, and
functional capacity should be periodically re-evaluated. The maximum daily dose
should not exceed 50 mg/day and the maximum single dose should not exceed 25 mg
if administered in conjunction with a strong CYP2D6 inhibitor (e,g.,
fluoxetine, paroxetine). In case of Neuroleptic Malignant Syndrome, the
treatment should be discontinued. The dose should be reduced or discontinued if
patient experience restlessness, agitation, akathisia and parkinsonism, The
treatment may impair patient's ability to drive or operate complex machinery,
Tetrabenzine is not recommended in combination with other drugs that prolong
QTc.
Overdose Effects
Signs and symptoms of
overdosage of Ticstop may include drowsiness, sweating and hypothermia.
Therapeutic Class
Atypical neuroleptic
drugs
Storage Conditions
Store in a cool &
dry place. protect from light & moisture. Keep all medicines out of the
reach of the children.
Login Or Registerto submit your questions to seller
No none asked to seller yet